According to the statistics of the WHO, the number of people suffering from cancer in the world is close to 20 million, and the number in China is as high as more than 4 million, and there is a trend of younger people.

There is no doubt that this has become the largest consumer market for anti-cancer drugs for pharmaceutical companies.

With so many resources invested in the research and development of new drugs, Ruihui will definitely not give up such a large market share, and it must be firmly controlled in the hands of the company.

Therefore, the negotiation of access to health insurance is particularly important.

It is necessary to win this order, but also not to let the other party lower the price.

This brings the importance of negotiation to life.

He deliberately sent Payina as a negotiator to attach enough importance to this negotiation.

Different from previous negotiations, the new drugs they developed are more effective for common types of cancer, and they are confident that they can crush the same type of anti-cancer drugs, and there is no shortage of buyers who naturally have enough weight to stabilize the price.

Relying on this will allow you to have a say in the negotiations.

Coupled with Payina's strength, he is very confident in this negotiation.

At this point in the meeting, after reconfirming all the details of the official launch of the new drug, Aibole announced the end of the meeting.

——

Two days later.

On the occasion of the arrival of the new working day, Ruihui officially launched a new anti-cancer drug to the world.

The new drug, named Rolagnib, costs more than $5,000 per bottle.

When the news attracted attention, it quickly became a hot topic of public discussion around the world.

And what everyone is most concerned about is naturally the effect of the drug, and the price that is so expensive.

Overseas may have been more receptive, and the response was not very large, but domestic netizens exploded one after another.

In recent years, cancer has gradually progressed towards a younger age, and many young people have been diagnosed with cancer, which inevitably causes anxiety and worry.

I was worried that I didn't know when cancer would find me.

It should be a good thing to see the advent of anti-cancer drugs with strong therapeutic effects.

It's worth everyone to celebrate.

After all, this is equivalent to further defeating cancer, so that cancer patients have a better chance of prolonging their lives.

But in the face of the price of more than 30,000 per bottle, most people are silent.

Because they know very well that even if they do have cancer, they can't afford this kind of price.

You must know that anti-cancer drugs are not just a bottle and you will be fine.

In response to this situation, netizens also launched a heated discussion, some people think that the pricing of anti-cancer drugs should be reduced, some people think that it is normal for pharmaceutical companies to invest so much money in the early stage and price it higher, and some people later extended to the essence of domestic anti-cancer drugs.

There is no doubt that domestic anti-cancer drugs are much cheaper, but the efficacy is much worse than that of imported drugs.

This is also the reason why many patients have to take imported medicines even if they smash pots and sell iron.

Everyone wants to live.

It's human nature.

"This Rolagoni is simply a miracle drug, even pancreatic cancer, which is known as the king of cancer, can have an effect, and Ruihui deserves to be a top pharmaceutical company."

"Blessed are cancer patients, maybe they can control their condition."

"It's good to have a good effect, but it's a pity that the price is too expensive."

"What imported medicine does not import medicine, does it have anything to do with us, anyway, we can't afford it."

"Thirty or forty thousand bottles are to rob money, even if it is a middle-class family, it won't last long."

"Eat your family and your relatives to death."

"When Pfizer makes so much money every year, it should lower its pricing so that more cancer patients can take medicine."

"People are not charities, why should the new drug developed by investing a large amount of money be given to you at a low price, I can only hope that this new drug can be included in the medical insurance reimbursement list."

"It's not that our own anti-cancer drugs can't work, and I don't know when there will be domestic anti-cancer drugs that are resounding all over the world."

……

A large number of hot search topics are hanging on major platforms, and the number of content readings and discussions has increased rapidly.

More and more people are getting involved in the discussion.

During the period, it is worth mentioning that some people also expressed the hope that Xu Yun could participate in the research and development of anti-cancer drugs.

The project that Xu Yun is in charge of has never failed, and if he takes over the research and development of anti-cancer drugs, there may be surprises, which will be equivalent to saving the lives of countless cancer patients.

The credit for this is not comparable to that of individual research devices.

Because life is priceless at all times.

However, as soon as similar remarks came out, they were refuted by others.

Everyone knows that Xu Yun is good at mathematics, as well as materials, artificial intelligence, quantum computers, and how to research anti-cancer drugs if they are completely unrelated to medicine.

It's not the same as letting a math student teach biology, except that there is nothing to be gained by losing a good mathematician.

No matter how strong Xu Yun's talent is, after all, there is only one person, and in the face of so many technical weaknesses in China, everyone still has to work together.

It's a pity that everyone doesn't know that although Xu Yun has not researched anti-cancer drugs, he has participated in the chimeric antigen receptor T cell immunotherapy project.

The popularity of Pfizer's new drug lasted on the Internet for a few days, and then it gradually returned to calm.

However, patients and their families in the oncology departments of major hospitals in China have begun to try various methods, hoping to buy Ruihui's new anti-cancer drug Rolagnib in advance.

Even if you pay more than you sell.

But there is no way to do it, according to the normal process, it takes time to buy this medicine in China.

If the process is cumbersome, it will be normal to wait for a few months.

Pfizer can wait for cancer patients, but it can't.

For them, time is of the essence, and if they don't hurry, they won't survive that day.

Especially for cancer patients who are already in the middle and advanced stages, this bottle of medicine is their lifesaver.

Even if you go bankrupt, you have to hold on tightly.

When death is approaching, how many people can calmly accept their fate in the face of that fear from genes.

If there is no hope, it is just that, and you can only be forced to accept your fate and face death.

But now there is hope, so it will be difficult to give up on your own initiative.

Soon.

As the time came to the end of the month, when Rolagini was sought after and snapped up by patients in the anti-cancer drug market, Payina, as an executive of Ruihui Biologics, finally made an appointment to leave for the imperial capital to negotiate.

"Move this itinerary forward, and we'll fly there when the negotiations are over."

At this moment, in the first-class cabin of an airline plane, Payina, who was still smartly dressed, sat on the seat and lowered her gaze to busy her work, and at the same time instructed the accompanying female assistant.

As a company executive, she has a lot of work to do, and spends most of her time flying around the world.

This requires the use of time as much as possible to ensure that the subsequent trip is not delayed.

The accompanying blonde female assistant took over the itinerary and looked at it, expressing some concern.

"If you advance it, will it make the negotiation time too tight, the company attaches great importance to the outcome of the negotiation."

As we all know, business negotiation is a technical task that pulls each other on, not to mention the huge interests involved.

It is too difficult to end in a short period of time, and it often takes several rounds of negotiations to meet the psychological expectations of both parties, and then successfully sign the contract and return.

The assistant naturally understood the importance that the boss Ai Bole attached to the negotiation, and wanted to take this opportunity to win the market, otherwise he would not have filmed Paina as the company's representative to negotiate with the medical insurance personnel.

In this case, Paina shortened the negotiation time, and if she did not stay in the imperial capital enough to complete the negotiations, she would not be able to complete the tasks assigned by the company, and she might even cause the dissatisfaction of her own boss and punish her.

Considering these factors, she reminded her as an assistant, hoping that Payina would pay enough attention.

But perhaps it was too much confidence or too much belief in her own strength, and Paina didn't worry about anything.

Confident that you will win this negotiation.

After listening to the assistant's words, he temporarily stopped what he was doing, raised his eyes and glanced at him, and said confidently.

"This negotiation won't take too long, I don't want to waste all my time here, so I'd better advance the next trip as much as possible."

"Won't it be too long?" The assistant was a little surprised when he heard this.

Perhaps because the two had been together for a long time and had some feelings for each other, Payina did not show impatience.

On the contrary, he immediately explained to the assistant.

"This is not the first time that our pharmaceutical company has cooperated with each other, and it will be much simplified with the previous basic process."

"The most important thing is that our Rolagoni has no medicine to replace, we don't need to kill the price at all, we just need to ensure the initiative and believe that the other party will agree soon."

"I see, I see." Listen to all the conversations between the two, and the assistant nodded.

……

Because the latest new anti-cancer drug Rolagnib has caused a huge storm on the Internet some time ago, the medical insurance personnel are naturally no stranger to it and are still very familiar with it, and now Ruihui has taken the initiative to express its willingness to cooperate and sent representatives, which is definitely a happy thing for them, if the negotiation goes well, patients can eat lower Rolagnib.

In order to show the sincerity of his side, after getting the flight information, he sent personnel to greet him.

"Director Liu."

"Do you think we can successfully complete the task assigned by the bureau this time, this price is too difficult."

In the waiting hall of the Imperial Capital Airport, Liu Xuezhi, the person in charge of medical insurance, also looked bitter when he listened to his assistant's inquiry.

After receiving the task, he checked the detailed information, and although there were all kinds of comments about the drug because it had just been launched, he was able to determine that this anti-cancer drug did have a more obvious effect on cancer.

If the patient continues to take it, it is enough to prolong life.

But because of this, they fell into passivity in the negotiations, and there was no substitute for domestic anti-cancer drugs.

Especially when I think of the psychological price given to him above, I feel even more impossible to achieve.

"Let's take one step at a time, if you can't do it, you can only apply to the above."

He sighed first, and then told the other party his intentions.

In the face of this situation, he can only try his best, if the other party still does not accept the price given by his side, then he can only apply for a price increase, and the negotiation must be completed no matter what.

Because it will be the hope of life for cancer patients.

After hearing this, the assistant next to him immediately didn't say anything more, and waited patiently for the arrival of the Negotiator from Ruihui.

Liu Xuezhi and Paina's rendezvous did not have so many twists and turns, and they recognized each other soon after the plane arrived.

"Hello Ms. Payina, welcome to the imperial capital, we have already arranged the hotel."

Liu Xuezhi hurriedly greeted Pa Yina when he saw him, with a smile on his face to make himself as kind as possible.

The two assistants next to him remained silent to prevent the important negotiations from being affected.

At this time, Paina naturally didn't put on a show, and immediately asked with a smile on the corner of her mouth.

"You're Director Liu, you're in trouble."

And almost the moment her words sounded, Liu Xuezhi's eyes suddenly widened, and surprise appeared on his face.

Subconsciously asked, "I didn't expect Ms. Payina to know Chinese?" ”

That's right.

The language that Paina responded to just now was not a foreign language, but a familiar language.

Despite the strong accent.

"I love it." Payina nodded and reconfirmed.

According to the normal process, the person who receives the person will send him to the hotel first, and then officially start work after resting.

Originally, Liu Xuezhi arranged it like this, and was ready to wait until he understood it before discussing the negotiation.

Unexpectedly, when he was about to lead the way in front, Paina's voice was heard in his ears again.

"Director Liu."

"Let's start work first, this time I can stay is really limited, I hope to complete the negotiations as soon as possible."

"It's good to return to the company."

If Liu Xuezhi was only worried about the negotiation process just now, then he was surprised after listening to Payina's words at this moment.

I really didn't expect the other party to be a workaholic.

After sitting on the plane for such a long time, she has to start work as soon as she gets off, and she is simply a proper strong woman.

I don't have the slightest personal time for myself.

However, out of politeness, he still made a proper suggestion.

"Ms. Payina, you have come from afar to rest for the night, and then work tomorrow."

"I'm fine, please take me to work." Paina said with a smile still on her face.

Speaking of which, Liu Xuezhi had no good way but to agree to the other party's request to go to the negotiation place first.

At the same time, he also instructed his subordinates to make arrangements in advance.

In this way, the group took a special car and soon arrived at the negotiation room of the medical insurance office building.

In the past, there would be negotiations with several pharmaceutical companies at the same time on the purchase price of drugs in this negotiation room, but because the situation is more special today, only Ruihui's Paina and her assistant.

As for Liu Xuezhi's side, there are only a few accompanying people.

In the afternoon negotiation room, Payina took a document from her assistant and took the initiative to hand it to Liu Xuezhi.

And explained: "We Ruihui are very sincere in wanting to reach cooperation with each other this time, which is the price of drugs that we can compromise." ”

After listening to Payina's words, Liu Xuezhi immediately focused on the document.

As the minutes passed, his face became more and more ugly.

At the beginning, he also thought that Ruihui really came with sincerity this time, hoping to reach cooperation.

But after seeing the price after the other party gave in, he suddenly understood that he had thought too much about his daring.

The next second, he closed the document and asked with some dissatisfaction: "It is only a few thousand yuan lower than the original price, which is not the price that centralized procurement should be." ”

According to the content of the document handed over by Payina, they still have to purchase more than 30,000 yuan per bottle.

This price is meaningless for patients at all, and it still cannot reduce the burden of taking medicine.

You must know that according to the above requirements, their ideal price should be reduced to 20,000 or even below 10,000 at most.

At the moment, it is clear that there is too much difference between the two prices.

And Pa Yina seemed to have expected Liu Xuezhi's reaction a long time ago, and continued to say with a calm face:

"Director Liu, you should be aware of the effect of the new drug Rolagnib, its efficacy is irreplaceable by any anti-cancer drug in the world, and it also has obvious effects in the treatment of pancreatic cancer in addition to common cancers."

"I think it's totally worth the price."

Liu Xuezhi admits that what Paina said is basically not wrong, but after all, it is a centralized procurement, and there is still a big difference between it and retail purchases.

He must be firm in his convictions.

"This price is far beyond our acceptable range, and if it has to be, I'm afraid the cooperation will not be completed."

It's a pity that this tough attitude didn't cause Payina to give in, and the next second I saw her stand up directly, and her attitude was even tougher than Liu Xuezhi's.

"We're not going to lower the price, and we hope you'll think about it again, and I'll only be here for three days."

After saying this, Payina no longer hesitated, and immediately turned around and left with her assistant.

It can be described as quite decisive.

This made Liu Xuezhi and the others' faces extremely ugly, and they really didn't expect it to become like this.

This is the first time they have had many negotiations, large and small, that has happened.

"Director, what should we do now?"

When only Liu Xuezhi and others were left in the negotiation room, the assistant next to him couldn't help but ask.

After all, they are indeed a bit difficult to ride now.

"Let's report to the above first, I'm afraid that this cooperation with Ruihui will be difficult to reach smoothly."

Listening to the assistant's voice in his ears, Liu Xuezhi sighed and replied with a somewhat lonely expression.

He is well aware of the bureau's attitude, and if the amount of money spent on centralized procurement at this price is too large, it will basically not be agreed by others.

The only regret is that it may be difficult for those cancer patients to get cheap new anti-cancer drugs.

It is worth mentioning that compared to Liu Xuezhi, the representative of Ruihui Biotech, who has returned to the hotel, Pa Yina, has the opposite idea, and she firmly believes that the other party will definitely accept her price.

"Wouldn't that be a bit too risky, will the other party really agree to the price we offered?"

"In case they abandon the purchase ......"

"They'll definitely say yes." In the hotel room, Paina interrupted the female assistant's tone and said affirmatively: "Our anti-cancer drugs are irreplaceable, even if they don't want to buy them at this price, those cancer patients will definitely not just give up." ”

"I see."

Hearing this, although the female assistant nodded, she still felt uneasy in her heart, and always felt that things were not so simple.

In fact, according to the boss's arrangement, this price can continue to be lowered and floated downward, but Payina refused to do so.

In a way, this is all about betting that the other party will eventually have no choice but to accept the price.

I have to say that Payina is indeed very courageous and can seize the advantages of her own products, but she does not know that the chimeric antigen receptor T cell immunotherapy developed by the Deepin Technology Biological Research Laboratory is about to end the trial approval and be marketed.

……

(End of chapter)